Skip to content
10-K

Annual Report

Eton Pharmaceuticals, Inc. ETON

0001437749-26-009059

← back to feed
Filed
Mar 19, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 17, 2026 27.28M sh
Capex FY 2025 · Dec 31, 2025 $333K
Capex FY 2025 · Dec 31, 2024 $26K
Capex FY 2025 · Dec 31, 2023 $0
Operating Cash Flow FY 2025 · Dec 31, 2025 $10.52M
Operating Cash Flow FY 2025 · Dec 31, 2024 $969K
Operating Cash Flow FY 2025 · Dec 31, 2023 $6.82M
Long Term Debt FY 2025 · Dec 31, 2025 $21.77M
Long Term Debt FY 2025 · Dec 31, 2024 $29.81M
Cash And Equivalents FY 2025 · Dec 31, 2025 $25.94M
Cash And Equivalents FY 2025 · Dec 31, 2024 $14.94M
Stockholders Equity FY 2025 · Dec 31, 2025 $26.15M
Stockholders Equity FY 2025 · Dec 31, 2024 $24.43M
Stockholders Equity FY 2025 · Dec 31, 2023 $15.48M
Stockholders Equity FY 2025 · Dec 31, 2022 $13.08M
Current Liabilities FY 2025 · Dec 31, 2025 $38.49M
Current Liabilities FY 2025 · Dec 31, 2024 $19.95M
Total Liabilities FY 2025 · Dec 31, 2025 $65.96M
Total Liabilities FY 2025 · Dec 31, 2024 $51.7M
Current Assets FY 2025 · Dec 31, 2025 $60.58M
Current Assets FY 2025 · Dec 31, 2024 $41.02M
Total Assets FY 2025 · Dec 31, 2025 $92.11M
Total Assets FY 2025 · Dec 31, 2024 $76.12M
Eps Basic FY 2025 · Dec 31, 2025 −$0.17
Eps Basic FY 2025 · Dec 31, 2024 −$0.15
Eps Basic FY 2025 · Dec 31, 2023 −$0.04
Sga Expense FY 2025 · Dec 31, 2025 $35.82M
Sga Expense FY 2025 · Dec 31, 2024 $22.75M
Sga Expense FY 2025 · Dec 31, 2023 $18.93M
Rd Expense FY 2025 · Dec 31, 2025 $7.77M
Rd Expense FY 2025 · Dec 31, 2024 $3.26M
Rd Expense FY 2025 · Dec 31, 2023 $3.32M
Net Income FY 2025 · Dec 31, 2025 −$4.6M
Net Income FY 2025 · Dec 31, 2024 −$3.82M
Net Income FY 2025 · Dec 31, 2023 −$936K
Operating Income FY 2025 · Dec 31, 2025 −$844K
Operating Income FY 2025 · Dec 31, 2024 −$2.6M
Operating Income FY 2025 · Dec 31, 2023 −$1.19M
Gross Profit FY 2025 · Dec 31, 2025 $42.74M
Gross Profit FY 2025 · Dec 31, 2024 $23.41M
Gross Profit FY 2025 · Dec 31, 2023 $21.06M
Cost Of Revenue FY 2025 · Dec 31, 2025 $37.21M
Cost Of Revenue FY 2025 · Dec 31, 2024 $15.6M
Cost Of Revenue FY 2025 · Dec 31, 2023 $10.58M
Revenue FY 2025 · Dec 31, 2025 $79.95M
Revenue FY 2025 · Dec 31, 2024 $39.01M
Revenue FY 2025 · Dec 31, 2023 $31.64M